Avinger Inc (AVGR) Stock Price & Overview
NASDAQ:AVGR • US0537348775
Current stock price
The current stock price of AVGR is 0.474 USD. Today AVGR is down by -20.74%. In the past month the price decreased by -19.65%. In the past year, price decreased by -84.07%.
AVGR Key Statistics
- Market Cap
- 1.569M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -11.03
- Dividend Yield
- N/A
AVGR Stock Performance
AVGR Stock Chart
AVGR Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to AVGR. When comparing the yearly performance of all stocks, AVGR is a bad performer in the overall market: 97.85% of all stocks are doing better.
AVGR Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to AVGR. While AVGR seems to be doing ok healthwise, there are quite some concerns on its profitability.
AVGR Earnings
On November 7, 2024 AVGR reported an EPS of -1.82 and a revenue of 1.65M. The company beat EPS expectations (12.1% surprise) and missed revenue expectations (-1.08% surprise).
AVGR Forecast & Estimates
7 analysts have analysed AVGR and the average price target is 5.1 USD. This implies a price increase of 975.95% is expected in the next year compared to the current price of 0.474.
For the next year, analysts expect an EPS growth of -30.64% and a revenue growth -12.9% for AVGR
AVGR Groups
Sector & Classification
AVGR Financial Highlights
Over the last trailing twelve months AVGR reported a non-GAAP Earnings per Share(EPS) of -11.03. The EPS increased by 66.4% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -127.59% | ||
| ROE | -447.82% | ||
| Debt/Equity | 0 |
AVGR Ownership
AVGR Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 18.66 | 186.262B | ||
| ISRG | INTUITIVE SURGICAL INC | 46.63 | 170.438B | ||
| SYK | STRYKER CORP | 22.42 | 130.023B | ||
| BSX | BOSTON SCIENTIFIC CORP | 20 | 103.709B | ||
| EW | EDWARDS LIFESCIENCES CORP | 27.34 | 47.893B | ||
| IDXX | IDEXX LABORATORIES INC | 38.8 | 46.168B | ||
| BDX | BECTON DICKINSON AND CO | 11.53 | 44.57B | ||
| RMD | RESMED INC | 18.38 | 33.129B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 13.53 | 32.076B | ||
| DXCM | DEXCOM INC | 26.4 | 25.89B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.55 | 17.577B | ||
| HOLX | HOLOGIC INC | 15.36 | 16.817B | ||
| PODD | INSULET CORP | 35.12 | 16.096B |
Related stock screener links
View all stocks in the Health Care Equipment Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About AVGR
Company Profile
Avinger, Inc. is a commercial-stage medical device company, which engages in the designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease. The company is headquartered in Redwood City, California and currently employs 68 full-time employees. The company went IPO on 2015-01-30. The firm designs, manufactures, and sells real-time, image-guided, minimally invasive catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). Its Lumivascular platform includes the Lightbox real-time imaging console, the Ocelot and Tigereye family of catheters, which are image-guided catheters designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and the Pantheris family of catheters, its image-guided atherectomy family of catheters designed to allow physicians to remove arterial plaque in PAD patients. Its Pantheris is a single-use product and provides physicians with the ability to see a cross-sectional view of the peripheral artery to guide the removal of blockages throughout the procedure. The company has also developed a line extension of its Pantheris image-guided atherectomy platform, Pantheris Small Vessel (SV).
Company Info
IPO: 2015-01-30
Avinger Inc
400 Chesapeake Dr
Redwood City CALIFORNIA 94063 US
CEO: Jeffrey M. Soinski
Employees: 71
Phone: 16503632400
Avinger Inc / AVGR FAQ
What does Avinger Inc do?
Avinger, Inc. is a commercial-stage medical device company, which engages in the designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease. The company is headquartered in Redwood City, California and currently employs 68 full-time employees. The company went IPO on 2015-01-30. The firm designs, manufactures, and sells real-time, image-guided, minimally invasive catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). Its Lumivascular platform includes the Lightbox real-time imaging console, the Ocelot and Tigereye family of catheters, which are image-guided catheters designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and the Pantheris family of catheters, its image-guided atherectomy family of catheters designed to allow physicians to remove arterial plaque in PAD patients. Its Pantheris is a single-use product and provides physicians with the ability to see a cross-sectional view of the peripheral artery to guide the removal of blockages throughout the procedure. The company has also developed a line extension of its Pantheris image-guided atherectomy platform, Pantheris Small Vessel (SV).
Can you provide the latest stock price for Avinger Inc?
The current stock price of AVGR is 0.474 USD. The price decreased by -20.74% in the last trading session.
Does AVGR stock pay dividends?
AVGR does not pay a dividend.
What is the ChartMill technical and fundamental rating of AVGR stock?
AVGR has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
Would investing in Avinger Inc be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on AVGR.
Who owns Avinger Inc?
You can find the ownership structure of Avinger Inc (AVGR) on the Ownership tab.